Search results
Bisphosphonates. In dogs, bisphosphonates are used as adjuvant therapy for the management of osteosarcoma. They inhibit osteoclast cells (bone busters), which are responsible for bone breakdown.
Compare Binosto vs Fosamax head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
The median time under treatment for all dogs is 83 days (range 13-971 days). The median time of treatment for the low dose group is 118 days (range 35-715 days). The median time of treatment for the high dose group is 83 days (range 13-971 days), the same as the overall group.
Medscape - Osteoporosis-specific dosing for Fosamax, Binosto (alendronate), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules,...
Four skeletally mature, male, intact dogs received a 15-minute i.v. infusion of zoledronate at a dosage of 0.25 mg/kg.
Dogs, initial dose: 1—2 mg/kg PO Q 8—12 H 39 Increase as needed to: 3—4 mg/kg PO Q 8—12 H 29: Primary adverse effects include, in humans, dry mouth, sedation, behavioral changes, and seizure potentiation; Codeine b Opioid: 0.5—2 mg/kg PO Q 12 H 39: Some suggest dogs only; Pharmacokinetics, but no clinical data, available; Gabapentin ...
29 lip 2000 · The bisphosphonate drug alendronate was used to suppress bone remodelling and tumour osteolysis as a palliative treatment for two dogs with osteosarcoma, one of the tibia and one of the maxilla.
